Found 6 matching trials
A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma
PHASE1This is a single-center, non-randomized study to evaluate the safety and ef...
Location
Peking Union Medical College Hospital
A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma
PHASE1This is a single-center, non-randomized and dose-escalation study to evalua...
A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma
PHASE1This is a single-center, non-randomized study to evaluate the safety and ef...
Location
Hebei Yanda Ludaopei Hospital
ASCT in Combination With C-CAR088 for Treating Patients With Ultra High-risk Multiple Myeloma (MM)
PHASE1This is a phase I/II, single-arm, open-lable study of autologous stem cell ...
Location
Institute of Hematology & Blood Diseases Hospital
A Study of C-CAR088 in Patients With Relapsed or Refractory Multiple Myeloma
PHASE1This is a multicenter, open-label study to evaluate the safety and efficacy...
Location
Institute of Hematology and Blood Diseases Hospital
A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma
PHASE1This is a single-center, non-randomized and dose-escalation study to evalua...
Location
the First Affiliated Hospital of Nanjing Medical University